Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Hammel, Pascal; Huguet, F.; Van Laethem, Jean‐Luc; Goldstein, David; Glimelius, Bengt; Artru, Pascal; Borbath, Ivan; Bouché, Olivier; Shannon, Jenny; André, Thierry; Mineur, Laurent; Chibaudel, Benoist; Bonnetain, Franck; Louvet, Christophe

doi:10.1001/jama.2016.4324

Public

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Published in JAMA • May 3, 2016

Authors:

Pascal Hammel

F. Huguet

Jean‐Luc Van Laethem

Abstract

IMPORTANCE: In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of erlotinib is unknown. OBJECTIVES: To assess whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemci...

Subject

Medicine

Gemcitabine

Erlotinib

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!